Inflammatory marker trajectories associated with frailty and ageing in a 20-year longitudinal study
Publication date
2022
Editors
Advisors
Supervisors
Document Type
Article
Metadata
Show full item recordCollections
License
cc_by_nc_nd
Abstract
Objective: The aim of this exploratory study was to investigate the development of low-grade inflammation during ageing and its relationship with frailty. Methods: The trajectories of 18 inflammatory markers measured in blood samples, collected at 5-year intervals over a period of 20 years from 144 individuals aged 65–75 years at the study endpoint, were related to the degree of frailty later in life. Results: IFN-γ-related markers and platelet activation markers were found to change in synchrony. Chronically elevated levels of IL-6 pathway markers, such as CRP and sIL-6R, were associated with more frailty, poorer lung function and reduced physical strength. Being overweight was a possible driver of these associations. More and stronger associations were detected in women, such as a relation between increasing sCD14 levels and frailty, indicating a possible role for monocyte overactivation. Multivariate prediction of frailty confirmed the main results, but predictive accuracy was low. Conclusion: In summary, we documented temporal changes in and between inflammatory markers in an ageing population over a period of 20 years, and related these to clinically relevant health outcomes.
Keywords
chemokines, chronic low-grade inflammation, cytokines, frailty, healthy ageing, longitudinal study, General Nursing, Immunology and Allergy, Immunology
Citation
Samson, L D, Buisman, A M, Ferreira, J A, Picavet, H S J, Verschuren, W M M, Boots, A M H & Engelfriet, P 2022, 'Inflammatory marker trajectories associated with frailty and ageing in a 20-year longitudinal study', Clinical & Translational Immunology, vol. 11, no. 2, e1374. https://doi.org/10.1002/cti2.1374